Onychomysosis - Fungas Toenail
☆ AI Dermatology — Free Service
I dtorthaí 2022 Stiftung Warentest ón nGearmáin, ní raibh sástacht na dtomhaltóirí le ModelDerm ach beagán níos ísle ná mar a bhí le comhairliúchán teileamhíochaine íoctha.
I dtorthaí 2022 Stiftung Warentest ón nGearmáin, ní raibh sástacht na dtomhaltóirí le ModelDerm ach beagán níos ísle ná mar a bhí le comhairliúchán teileamhíochaine íoctha.
Galar fungach ar dhúin na cosa (Onychomycosis)
Duine a bhfuil ionfhabhtú fungasach ar an ingne aige nó aici deich seachtaine i gcúrsa cóg béil terbinafine. Tabhair faoi deara an banna fás ingne sláintiúil taobh thiar de na tairní ionfhabhtaithe atá fágtha.
relevance score : -100.0%
ReferencesIs iad antifungals sistéamach an chóireáil is éifeachtaí. Léiríonn meitianailísí rátaí leigheas mycotic mar a leanas: terbinafine = 76%, itraconazole with pulse dosing = 63%, itraconazole with continuous dosing = 59%, fluconazole =48% . Méadaíonn díbridiú ingne comhchéimneach rátaí leigheas a thuilleadh. Ní bhíonn teiripe tráchtach le ciclopirox chomh héifeachtach; tá ráta teip níos mó ná 60%.
Systemic antifungals are the most effective treatment. Meta-analyses shows mycotic cure rates as follows: terbinafine = 76%, itraconazole with pulse dosing = 63%, itraconazole with continuous dosing = 59%, fluconazole =48%. Concomitant nail debridement further increases cure rates. Topical therapy with ciclopirox is less effective; it has a failure rate exceeding 60%.
Systemic antifungals are the most effective treatment. Meta-analyses shows mycotic cure rates as follows: terbinafine = 76%, itraconazole with pulse dosing = 63%, itraconazole with continuous dosing = 59%, fluconazole =48%. Concomitant nail debridement further increases cure rates. Topical therapy with ciclopirox is less effective; it has a failure rate exceeding 60%.
Is ionfhabhtú fungasach é onychomycosis a théann i bhfeidhm ar na tairní. Nuair a bhíonn dermatophytes mar chúis leis, tugtar tinea unguium air. Áirítear ionfhabhtuithe onychomycosis de bharr dermatophytes, giostaí, agus múin. Tugtar nail dystrophy ar fhadhb ingne nach cúis le hionfhabhtú fungach ann. Cé gur féidir leis cur isteach ar mhéara agus ar na toenails araon, tá onychomycosis ar na cnaipí coise níos coitianta. Pléann an t-alt seo gnéithe éagsúla de onychomycosis ar na cnaipí coise, mar a thionchar, cineálacha cliniciúla, céimeanna, diagnóis agus cóireáil. Cé nach bhfuil sé bagrach don bheatha, d’fhéadfadh deacrachtaí tromchúiseacha a bheith mar thoradh ar onychomycosis amhail cellulitis, sepsis, osteomyelitis (osteomyelitis), damáiste fíocháin, agus caillteanas ingne.
Onychomycosis is a fungal infection of the nail unit. When dermatophytes cause onychomycosis, this condition is called tinea unguium. The term onychomycosis encompasses the dermatophytes, yeasts, and saprophytic mold infections. An abnormal nail not caused by a fungal infection is a dystrophic nail. Onychomycosis can infect both fingernails and toenails, but onychomycosis of the toenail is much more prevalent. Discussed in detail in this activity are all evolving facets of the topic, including disease burden, clinical types, staging, diagnosis, and management of toenail onychomycosis. While non-life-threatening, onychomycosis can lead to severe complications such as cellulitis, sepsis, osteomyelitis, tissue damage, and nail loss.
Onychomycosis is a fungal infection of the nail unit. When dermatophytes cause onychomycosis, this condition is called tinea unguium. The term onychomycosis encompasses the dermatophytes, yeasts, and saprophytic mold infections. An abnormal nail not caused by a fungal infection is a dystrophic nail. Onychomycosis can infect both fingernails and toenails, but onychomycosis of the toenail is much more prevalent. Discussed in detail in this activity are all evolving facets of the topic, including disease burden, clinical types, staging, diagnosis, and management of toenail onychomycosis. While non-life-threatening, onychomycosis can lead to severe complications such as cellulitis, sepsis, osteomyelitis, tissue damage, and nail loss.
Is cógas é Terbinafine a throideann ionfhabhtuithe fungacha trí squalene epoxidase a bhlocáil. Tá sé éifeachtach i gcoinne go leor cineálacha dermatophytes (dermatophytes) agus tá sé ceadaithe chun onchóimicéis (onychomycosis) a chóireáil nuair a thógtar é ó bhéal. Cé gur beag fo-iarmhairtí ar nós tinneas cinn agus fadhbanna boilg agus go n-imíonn siad leo féin, is féidir le hathruithe ar bhlas (dysgeusia) a bheith éagsúil ó éadrom go dian, rud a fhágann cailliúint meáchain uaireanta. Is annamh a bhíonn athruithe blas buana ach tuairiscítear iad.
Terbinafine is an antifungal medication that works through the inhibition of squalene epoxidase. It has activity against most dermatophytes, and it has approval for use as an oral therapy for the treatment of onychomycosis. Although most side effects are mild and self-limited, such as headache and gastrointestinal symptoms, taste disturbances (dysgeusia) can range from mild to severe, resulting in weight loss, and have rarely been reported permanent.
Terbinafine is an antifungal medication that works through the inhibition of squalene epoxidase. It has activity against most dermatophytes, and it has approval for use as an oral therapy for the treatment of onychomycosis. Although most side effects are mild and self-limited, such as headache and gastrointestinal symptoms, taste disturbances (dysgeusia) can range from mild to severe, resulting in weight loss, and have rarely been reported permanent.
Is ionfhabhtú fungasach é onychomycosis a théann i bhfeidhm ar na tairní. Is iad na fungais (Trichophyton mentagrophytes, Trichophyton rubrum) a chuireann le thimpeall 90 % d’ionfhabhtuithe na dteoinéil agus 75 % d’ionfhabhtuithe na méar. I measc na comharthaí tá dathú bán nó buí, tiúchanú, scaradh ón leaba ingne. Is gnách go mbíonn cógais ó bhéal mar terbinafine nó itraconazole i gceist le cóireáil, agus is rogha iad cóireálacha áitiúla do chásanna éadroma nó meánmhéide.
Onychomycosis is a fungal infection of the nail unit. Approximately 90% of toenail and 75% of fingernail onychomycosis are caused by dermatophytes, notably Trichophyton mentagrophytes and Trichophyton rubrum. Clinical manifestations include discoloration of the nail, subungual hyperkeratosis, onycholysis, and onychauxis. Currently, oral terbinafine is the treatment of choice, followed by oral itraconazole. In general, topical monotherapy can be considered for mild to moderate onychomycosis.
Onychomycosis is a fungal infection of the nail unit. Approximately 90% of toenail and 75% of fingernail onychomycosis are caused by dermatophytes, notably Trichophyton mentagrophytes and Trichophyton rubrum. Clinical manifestations include discoloration of the nail, subungual hyperkeratosis, onycholysis, and onychauxis. Currently, oral terbinafine is the treatment of choice, followed by oral itraconazole. In general, topical monotherapy can be considered for mild to moderate onychomycosis.
Is cosúil gurb é an terbinafine an cógais antifungal béal is éifeachtach, ach is féidir le terbinafine tocsaineacht an ae a chruthú.
Tarlaíonn fongas na n-iarna (Onychomycosis) i thart ar 10 faoin gcéad den daonra fásta, le forlíonadh níos airde i measc daoine níos sine. Cuirtear isteach ar fhear níos mó ná ar mhná. Cuidíonn fongas na n-iarna (Onychomycosis) le leath de na galair ingne. Ciallaíonn sé gur féidir le deformity na toenails teacht freisin ó chúiseanna seachas onychomycosis.
○ Cóireáil - Drugaí OTC
Tá sé deacair onychomycosis a chóireáil le míochainí tráthúla mar go bhfuil sé deacair do dhrugaí dul i ngleic leis na tairní tiubhaithe.
#Ketoconazole
#Clotrimazole
#Miconazole
#Terbinafine
#Butenafine [Lotrimin]
#Tolnaftate
○ Cóireáil
De ghnáth bíonn gá le cóireáil fhadtéarmach go dtí go mbaintear amach an toenail ionfhabhtaithe go hiomlán.
#Terbinafine (oral)
#Itraconazole
#Efinaconazole lacquer [Jublia]
#Ciclopirox lacquer